CNR1 and obesity disorder: Moreover, the CB1 activation promotes adipogenesis, liver lipogenesis, and may exert a pro-inflammatory effect [215] while CB2 mediates inhibition of obese-related inflammation and thus decreases the risk of adverse outcomes in obesity [214].